JP2016512513A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512513A5 JP2016512513A5 JP2016500995A JP2016500995A JP2016512513A5 JP 2016512513 A5 JP2016512513 A5 JP 2016512513A5 JP 2016500995 A JP2016500995 A JP 2016500995A JP 2016500995 A JP2016500995 A JP 2016500995A JP 2016512513 A5 JP2016512513 A5 JP 2016512513A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- individual
- item
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 claims description 12
- 229940123237 Taxane Drugs 0.000 claims description 12
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 239000002105 nanoparticle Substances 0.000 claims description 9
- 102000009027 Albumins Human genes 0.000 claims description 8
- 108010088751 Albumins Proteins 0.000 claims description 8
- 208000006678 Abdominal Neoplasms Diseases 0.000 claims description 2
- 208000018084 Bone neoplasm Diseases 0.000 claims description 2
- 206010029260 Neuroblastoma Diseases 0.000 claims description 2
- 229930012538 Paclitaxel Natural products 0.000 claims description 2
- 206010039491 Sarcoma Diseases 0.000 claims description 2
- 206010068771 Soft tissue neoplasm Diseases 0.000 claims description 2
- 208000021712 Soft tissue sarcoma Diseases 0.000 claims description 2
- 208000024519 eye neoplasm Diseases 0.000 claims description 2
- 229960001592 paclitaxel Drugs 0.000 claims description 2
- 230000000306 recurrent effect Effects 0.000 claims description 2
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 25
- 238000000034 method Methods 0.000 description 21
- 230000002250 progressing effect Effects 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780658P | 2013-03-13 | 2013-03-13 | |
| US61/780,658 | 2013-03-13 | ||
| US201361805817P | 2013-03-27 | 2013-03-27 | |
| US61/805,817 | 2013-03-27 | ||
| US201361829940P | 2013-05-31 | 2013-05-31 | |
| US61/829,940 | 2013-05-31 | ||
| US201361909868P | 2013-11-27 | 2013-11-27 | |
| US61/909,868 | 2013-11-27 | ||
| PCT/US2014/022541 WO2014143613A1 (en) | 2013-03-13 | 2014-03-10 | Methods of treatment of pediatric solid tumor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018009402A Division JP2018062528A (ja) | 2013-03-13 | 2018-01-24 | 小児充実性腫瘍の処置の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512513A JP2016512513A (ja) | 2016-04-28 |
| JP2016512513A5 true JP2016512513A5 (enExample) | 2017-04-06 |
| JP6387389B2 JP6387389B2 (ja) | 2018-09-05 |
Family
ID=51537501
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500995A Active JP6387389B2 (ja) | 2013-03-13 | 2014-03-10 | 小児充実性腫瘍の処置の方法 |
| JP2018009402A Withdrawn JP2018062528A (ja) | 2013-03-13 | 2018-01-24 | 小児充実性腫瘍の処置の方法 |
| JP2019124315A Pending JP2019163334A (ja) | 2013-03-13 | 2019-07-03 | 小児充実性腫瘍の処置の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018009402A Withdrawn JP2018062528A (ja) | 2013-03-13 | 2018-01-24 | 小児充実性腫瘍の処置の方法 |
| JP2019124315A Pending JP2019163334A (ja) | 2013-03-13 | 2019-07-03 | 小児充実性腫瘍の処置の方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160015817A1 (enExample) |
| EP (1) | EP2968253A4 (enExample) |
| JP (3) | JP6387389B2 (enExample) |
| KR (1) | KR20150126671A (enExample) |
| CN (1) | CN105209035A (enExample) |
| AU (2) | AU2014228386B2 (enExample) |
| CA (1) | CA2903470A1 (enExample) |
| HK (1) | HK1219231A1 (enExample) |
| IL (1) | IL240987A0 (enExample) |
| MX (1) | MX2015011783A (enExample) |
| NZ (1) | NZ630367A (enExample) |
| WO (1) | WO2014143613A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| US9675578B2 (en) | 2006-12-14 | 2017-06-13 | Abraxis Bioscience, Llc | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| HRP20192259T1 (hr) | 2009-04-15 | 2020-03-06 | Abraxis Bioscience, Llc | Pripravci nanočestica bez priona i metode njihove proizvodnje |
| KR20130028727A (ko) | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
| US9393318B2 (en) | 2010-03-29 | 2016-07-19 | Abraxis Bioscience, Llc | Methods of treating cancer |
| KR20130088116A (ko) | 2010-06-04 | 2013-08-07 | 아브락시스 바이오사이언스, 엘엘씨 | 췌장암의 치료 방법 |
| AU2012249371B2 (en) | 2011-04-28 | 2017-06-08 | Abraxis Bioscience, Llc | Intravascular delivery of nanoparticle compositions and uses thereof |
| PL2790675T3 (pl) | 2011-12-14 | 2019-12-31 | Abraxis Bioscience, Llc | Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| JP6349381B2 (ja) | 2013-03-12 | 2018-06-27 | アブラクシス バイオサイエンス， エルエルシー | 肺がんを処置する方法 |
| JP6309610B2 (ja) | 2013-03-14 | 2018-04-11 | アブラクシス バイオサイエンス， エルエルシー | 膀胱がんを処置する方法 |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| SMT202100642T1 (it) | 2015-06-29 | 2022-03-21 | Abraxis Bioscience Llc | Nanoparticelle comprendenti sirolimus e un'albumina per l'uso nel trattamento di tumori a cellule epitelioidi |
| AU2019239953B2 (en) | 2018-03-20 | 2025-01-02 | Abraxis Bioscience, Llc | Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin |
| IL292439B2 (en) | 2019-10-28 | 2026-05-01 | Abraxis Bioscience Llc | Pharmaceutical preparations of albumin and rapamycin |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| CN1101700C (zh) * | 1997-12-05 | 2003-02-19 | 上海众联生化技术开发有限公司 | 多肽口服液 |
| ITMI20001107A1 (it) * | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
| DK1585548T3 (en) | 2002-12-09 | 2018-09-03 | Abraxis Bioscience Llc | COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS |
| CN1261161C (zh) * | 2003-11-10 | 2006-06-28 | 钱汶光 | 复方干扰素诱生剂口含片 |
| CN103169729A (zh) | 2005-02-18 | 2013-06-26 | 阿布拉科斯生物科学有限公司 | 治疗剂的组合和给予方式以及联合治疗 |
| CN101291658B (zh) | 2005-08-31 | 2014-04-16 | 阿布拉科斯生物科学有限公司 | 用于制备稳定性增加的水难溶性药物的组合物和方法 |
| WO2008137148A2 (en) | 2007-05-03 | 2008-11-13 | Abraxis Bioscience, Llc | Methods and compositions for treating pulmonary hypertension |
| EP2502078A1 (en) * | 2009-11-20 | 2012-09-26 | Infinity Pharmaceuticals, Inc. | Methods and compositions for treating hedgehog-associated cancers |
| KR20130028727A (ko) * | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
| CN103221042B (zh) * | 2010-06-02 | 2016-02-10 | 阿布拉科斯生物科学有限公司 | 治疗膀胱癌的方法 |
-
2014
- 2014-03-10 CN CN201480026752.3A patent/CN105209035A/zh active Pending
- 2014-03-10 US US14/771,783 patent/US20160015817A1/en not_active Abandoned
- 2014-03-10 AU AU2014228386A patent/AU2014228386B2/en not_active Ceased
- 2014-03-10 HK HK16107309.3A patent/HK1219231A1/zh unknown
- 2014-03-10 NZ NZ630367A patent/NZ630367A/en unknown
- 2014-03-10 JP JP2016500995A patent/JP6387389B2/ja active Active
- 2014-03-10 WO PCT/US2014/022541 patent/WO2014143613A1/en not_active Ceased
- 2014-03-10 CA CA2903470A patent/CA2903470A1/en not_active Abandoned
- 2014-03-10 MX MX2015011783A patent/MX2015011783A/es unknown
- 2014-03-10 EP EP14763546.0A patent/EP2968253A4/en not_active Withdrawn
- 2014-03-10 KR KR1020157027992A patent/KR20150126671A/ko not_active Ceased
-
2015
- 2015-09-01 IL IL240987A patent/IL240987A0/en unknown
-
2018
- 2018-01-24 JP JP2018009402A patent/JP2018062528A/ja not_active Withdrawn
-
2019
- 2019-02-27 AU AU2019201357A patent/AU2019201357A1/en not_active Abandoned
- 2019-07-03 JP JP2019124315A patent/JP2019163334A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019013701A (es) | Metodos para mejorar suministro de farmacos y efectividad de agentes terapeuticos. | |
| Wieszczycka et al. | Lanthanides and tissue engineering strategies for bone regeneration | |
| JP2016513075A5 (enExample) | ||
| JP2016513097A5 (enExample) | ||
| JP2013503174A5 (enExample) | ||
| JP2016513657A5 (enExample) | ||
| JP2010509331A5 (enExample) | ||
| JP2013523656A5 (enExample) | ||
| JP2012520323A5 (enExample) | ||
| NZ708506A (en) | Methods of treating bladder cancer | |
| JP2016512506A5 (enExample) | ||
| JP2017226708A5 (enExample) | ||
| JP2013527233A5 (enExample) | ||
| RU2009121568A (ru) | Комбинации и способы введения терапевтических агентов и комбинированная терапия | |
| EA201890146A1 (ru) | СПОСОБЫ ЛЕЧЕНИЯ СОЛИДНЫХ ОПУХОЛЕЙ С ИСПОЛЬЗОВАНИЕМ КОМБИНИРОВАННОЙ ТЕРАПИИ ИНГИБИТОРОМ mTOR В ВИДЕ НАНОЧАСТИЦ | |
| JP2013533232A5 (enExample) | ||
| EA200701195A1 (ru) | Содержащие цефалоспорин композиции с наночастицами и с контролируемым высвобождением | |
| NZ593343A (en) | Combination cancer treatment conprising Abraxane and an inflamatory inhibitor | |
| JP2013527232A5 (enExample) | ||
| JP2021505540A5 (enExample) | ||
| JP2020523356A5 (enExample) | ||
| WO2015095834A3 (en) | Cancer treatments using erk1/2 and bcl-2 family inhibitors | |
| JP2019532047A5 (enExample) | ||
| JP2016515586A5 (enExample) | ||
| JP2010523696A5 (enExample) |